Volitionrx limited issues mid-year review ahead of 2024 annual meeting

Henderson, nev. , june 27, 2024 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, has issued a mid-year review to stockholders, ahead of its annual meeting of stockholders to be held on july 2, 2024.

VNRX Ratings Summary

VNRX Quant Ranking